China National Medicines Corp Ltd
SSE:600511
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
CN |
Multiples-Based Value
The Multiples-Based Value of one China National Medicines Corp Ltd stock under the Base Case scenario is 46.67 CNY. Compared to the current market price of 29.3 CNY, China National Medicines Corp Ltd is Undervalued by 37%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
China National Medicines Corp Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
China National Medicines Corp Ltd
SSE:600511
|
22.1B CNY | 0.4 | 11 | 7.5 | 7.5 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
107.3B USD | 0.3 | 24.7 | 17.4 | 19.5 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
61.9B USD | 0.2 | 38.1 | 13.5 | 17.1 | |
| US |
|
Cencora Inc
NYSE:COR
|
61.8B USD | 0.2 | 38.1 | 13.5 | 17.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50B USD | 0.2 | 30.1 | 14.5 | 18.9 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.4B AUD | 2.7 | 33.8 | 25.1 | 25.1 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.8B CNY | 0.2 | 11.1 | 8.7 | 8.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.7B CNY | 1.5 | 17.2 | 13.3 | 13.3 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.5B USD | 0.6 | 21.2 | 10.4 | 14.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64B HKD | 0.1 | 8.1 | 0.7 | 0.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |